Daily Ards Research Analysis
Mechanistic work links neutrophil-derived extracellular vesicles to monocyte-dependent renal endothelial inflammation in ARDS, suggesting new therapeutic targets for AKI. An exploratory cohort shows that sudden increases in exhaled CO2 have poor sensitivity but high specificity for ruling in bacterial superinfection in ventilated ARDS. A large trauma cohort highlights ARDS development as an independent mortality predictor in hypotensive trauma.
Summary
Mechanistic work links neutrophil-derived extracellular vesicles to monocyte-dependent renal endothelial inflammation in ARDS, suggesting new therapeutic targets for AKI. An exploratory cohort shows that sudden increases in exhaled CO2 have poor sensitivity but high specificity for ruling in bacterial superinfection in ventilated ARDS. A large trauma cohort highlights ARDS development as an independent mortality predictor in hypotensive trauma.
Research Themes
- Pathophysiology of organ cross-talk in ARDS and AKI
- Bedside diagnostic monitoring for superinfection in ventilated ARDS
- Trauma prognostication with ARDS-associated mortality risk
Selected Articles
1. Human neutrophil-derived extracellular vesicles induce renal endothelial inflammation in critical illness: an ex vivo investigation.
Ex vivo NEVs from healthy blood (LPS-stimulated) and from COVID-19 ARDS patients were internalized by monocytes, activating p38 MAPK and boosting TNF release, which in turn drove inflammatory activation of renal glomerular endothelial cells. Findings support a monocyte-dependent mechanism by which circulating NEVs contribute to AKI in ARDS and highlight p38/TNF pathways as potential targets.
Impact: Provides mechanistic evidence linking circulating NEVs to renal endothelial inflammation in ARDS, identifying actionable signaling pathways (p38 MAPK/TNF). Such organ cross-talk insights can guide targeted interventions for AKI in critical illness.
Clinical Implications: Suggests exploring therapeutics that modulate NEV signaling, p38 MAPK inhibition, or TNF pathways to prevent or mitigate AKI in ARDS. Biomarker development around NEVs could aid risk stratification for renal complications.
Key Findings
- NEVs were internalized by monocytes and activated them via p38 MAPK, increasing TNF release.
- NEV exposure led to inflammatory activation of renal glomerular endothelial cells in co-culture.
- Monocyte-dependent mechanisms mediated endothelial inflammation, implicating p38/TNF pathways as targets.
Methodological Strengths
- Use of patient-derived NEVs (COVID-19 ARDS) alongside LPS-stimulated healthy donor NEVs
- Co-culture of immune and endothelial cells with pharmacological pathway inhibition and multimodal readouts (ELISA, flow cytometry)
Limitations
- Ex vivo design with short incubation (4 h) limits direct in vivo generalizability.
- Sample size and patient heterogeneity are not fully detailed in the abstract; clinical outcomes were not assessed.
Future Directions: Validate NEV-mediated pathways in vivo, quantify NEV phenotypes in larger ARDS cohorts, and test p38/TNF-targeted interventions to prevent AKI.
BACKGROUND: Circulating neutrophil-derived extracellular vesicles (NEVs) may contribute to the pathophysiology of acute kidney injury by causing glomerular endothelial inflammation. METHODS: NEVs were first isolated from ex vivo, lipopolysaccharide stimulation of whole blood taken from healthy volunteers (median age [interquartile range {IQR}]: 32 [26-42] yr; 47% female), and also from plasma of COVID-19 patients with acute respiratory distress syndrome (median age [IQR]: 59 [52-66] yr; 45% female). NEVs were incubated for 4 h in a co-culture of peripheral blood mononuclear cells and either human umbilical vein endothelial cells or renal glomerular endothelial cells. Enzyme-linked immunoassays (tumour necrosis factor-alpha [TNF]) and flow cytometry (median fluorescence intensity [MFI]) were used to quantify cell-specific markers of inflammation/activation, in the presence/absence of pharmacological inhibitors. RESULTS: NEVs were internalised by monocytes, leading to their activation via the p38 mitogen-activated protein kinase pathway and increased release of TNF (median [IQR]: 676 [474-1731] pg ml CONCLUSIONS: Circulating NEVs may contribute to acute kidney injury through renal endothelial inflammation in a monocyte-dependent fashion in patients with acute respiratory distress syndrome.
2. Use of carbon dioxide production to detect bacterial superinfections in mechanically ventilated patients with acute respiratory distress syndrome: an exploratory prospective cohort study.
In 31 ventilated COVID-19 ARDS patients monitored over 150 ICU days, a first surge in daily median V'CO2 was not reliably associated with same-day bacterial superinfection and showed poor sensitivity (17%) but high specificity (94%). Superinfected patients had higher daily median V'CO2 overall, supporting potential rule-in use rather than rule-out.
Impact: Introduces continuous V'CO2 monitoring as a pragmatic, bedside biomarker candidate for superinfection in ventilated ARDS, with careful adjudication and trial registration. Negative yet informative findings refine diagnostic strategies.
Clinical Implications: Do not rely on V'CO2 surges to rule out superinfection; absence of increase is not reassuring. A marked V'CO2 rise may help rule in superinfection and prompt targeted diagnostics and therapy, potentially aiding antibiotic stewardship.
Key Findings
- First-day V'CO2 surge was not significantly associated with same-day superinfection (OR 3.47, 95% CI 0.64–18.92, p=0.15).
- Diagnostic sensitivity was low (17%, 95% CI 2%–48%) while specificity was high (94%, 95% CI 89%–98%).
- Patients with superinfection had higher daily median V'CO2 (210 mL/min) than those without (176 mL/min, p<0.001).
Methodological Strengths
- Prospective design with continuous volumetric capnography and protocolised microbiology sampling
- Adjudicated clinical interpretations and preregistration (NCT04410263)
Limitations
- Small, single-centre sample (31 patients) limits precision of diagnostic performance estimates.
- Restricted to COVID-19 ARDS; generalisability to non-COVID ARDS is uncertain.
Future Directions: Larger, multicentre cohorts across ARDS etiologies to validate thresholds, integrate V'CO2 with other biomarkers, and assess impact on antibiotic stewardship and outcomes.
BACKGROUND: Bacterial superinfections are common in patients with acute respiratory distress syndrome (ARDS) but diagnosing them is challenging. Exhaled carbon dioxide (V'CO2) may be increased during bacterial infection, suggesting a potential marker for detecting bacterial superinfections in ARDS patients. METHODS: In a prospective cohort study of mechanically ventilated adult patients with ARDS due to SARS-CoV-2 in a tertiary intensive care unit, we assessed V'CO2 measurements from continuous volumetric capnography and calculated daily median V'CO2 levels. The primary outcome was to determine if a first substantial increase in daily median V'CO2 was associated with a first bacterial superinfection. Protocolised microbiological sampling and adjudicated clinical interpretations were used to determine the onset of a first superinfection. RESULTS: A total of 150 days of continuous volumetric capnography were analysed in 31 mechanically ventilated adult patients with ARDS due to SARS-CoV-2. We observed 10 patients (32%) with a first episode of substantial increase of daily median V'CO2, and 12 (39%) patients with a first bacterial superinfection. A V'CO2 increase was not associated with a superinfection on the same day (OR 3.47, 95% CI 0.64 to 18.92, p=0.15, adjusted for age and gender). Investigating all 150 test days of median V'CO2 revealed a poor sensitivity (17%, 95% CI 2% to 48%) for detecting superinfections. However, a first V'CO2 increase indicated superinfection with high specificity (94%, 95% CI 89% to 98%). Patients with superinfections showed higher daily median V'CO2 levels (210 mL/min) than those without (176 mL/min, p<0.001), even after adjusting for age and gender (OR 1.56, 95% CI 1.16 to 2.08, p=0.003). CONCLUSIONS: A sudden increase in daily median V'CO2 did not reliably detect bacterial superinfections, which was reflected in a poor sensitivity and inability to rule out superinfections in patients without V'CO2 increase. Nevertheless, high specificity suggests that V'CO2 may be useful to rule in superinfections in patients with ARDS. TRIAL REGISTRATION NUMBER: NCT04410263.
3. Significance of a hypotensive episode following traumatic injury: A retrospective observational study.
Across 17,341 trauma admissions over 10 years, 6.9% had prehospital or arrival hypotension. Hypotension signaled higher severity and mortality, and among hypotensive trauma patients, development of ARDS independently predicted death, underscoring the need for aggressive early management.
Impact: Large-scale data identify ARDS development as an independent mortality predictor in hypotensive trauma, refining risk stratification beyond initial blood pressure alone.
Clinical Implications: In hypotensive trauma, monitor closely for ARDS and escalate care early; integrate ARDS risk into prognostic models to guide ICU admission and resource allocation.
Key Findings
- Among 17,341 trauma admissions, 1,188 (6.9%) had hypotension prehospital or on arrival.
- Hypotension was associated with increased injury severity and mortality.
- In hypotensive trauma patients, development of ARDS independently predicted mortality.
Methodological Strengths
- Large, decade-long cohort with clear hypotension definition (SBP ≤ 90 mmHg)
- Multivariable assessment identifying ARDS as an independent predictor
Limitations
- Retrospective, single-system dataset with potential unmeasured confounding.
- Limited granularity on ventilatory management and timing of ARDS onset.
Future Directions: Prospective validation incorporating physiologic trajectories and ventilator parameters; evaluate interventions targeting early ARDS prevention in hypotensive trauma.
BACKGROUND: Early hemodynamic assessment remains crucial for proper management in trauma settings. Hypotension is a vital indication in trauma patients to be considered upon initial triaging to assess the risk of bleeding and hypovolemic shock which entails significant clinical attention during initial resuscitation. AIM: To assess whether an initial episode of prehospital or emergency department hypotension is associated with an increased risk of morbidity and mortality in trauma patients. METHODS: A retrospective analysis was performed to include all trauma patients hospitalized between 2011 and 2021. Hypotension was defined as a systolic blood pressure ≤ 90 mmHg in the prehospital setting or upon arrival to the hospital. Patients were classified into normotensive RESULTS: Over the ten years, 17341 trauma admissions were analyzed, of which 1188 (6.9%) patients had hypotension episodes either at the scene or upon hospital arrival. Patients with hypotension were two years younger ( CONCLUSION: Hypotensive episodes following trauma are associated with higher severity and mortality. The development of ARDS is an independent predictor of mortality in hypotensive trauma patients. A hypotensive episode is a warning sign and calls for aggressive, timely management following trauma.